Index of /rsat/data/genomes/Actinomadura_graeca_GCF_019175365.1_ASM1917536v1/oligo-frequencies

[ICO]NameLast modifiedSizeDescription

[PARENTDIR]Parent Directory   -  
[   ]1nt_genomic_Actinoma..>2024-04-28 15:43 1.0K 
[   ]1nt_genomic_Actinoma..>2024-04-28 15:43 1.0K 
[   ]1nt_genomic_Actinoma..>2024-04-28 15:44 934  
[   ]1nt_genomic_Actinoma..>2024-04-28 15:45 931  
[   ]1nt_upstream-noorf_A..>2024-04-28 15:36 1.0K 
[   ]1nt_upstream-noorf_A..>2024-04-28 15:36 1.0K 
[   ]1nt_upstream-noorf_A..>2024-04-28 15:37 908  
[   ]1nt_upstream-noorf_A..>2024-04-28 15:37 900  
[   ]1nt_upstream_Actinom..>2024-04-28 15:39 1.0K 
[   ]1nt_upstream_Actinom..>2024-04-28 15:40 1.0K 
[   ]1nt_upstream_Actinom..>2024-04-28 15:40 897  
[   ]1nt_upstream_Actinom..>2024-04-28 15:41 892  
[   ]1pept_protein_Actino..>2024-04-28 15:47 964  
[   ]1pept_protein_Actino..>2024-04-28 15:49 868  
[   ]2nt_genomic_Actinoma..>2024-04-28 15:43 1.3K 
[   ]2nt_genomic_Actinoma..>2024-04-28 15:43 1.2K 
[   ]2nt_genomic_Actinoma..>2024-04-28 15:44 1.1K 
[   ]2nt_genomic_Actinoma..>2024-04-28 15:45 1.1K 
[   ]2nt_upstream-noorf_A..>2024-04-28 15:36 1.2K 
[   ]2nt_upstream-noorf_A..>2024-04-28 15:36 1.2K 
[   ]2nt_upstream-noorf_A..>2024-04-28 15:37 1.1K 
[   ]2nt_upstream-noorf_A..>2024-04-28 15:37 1.0K 
[   ]2nt_upstream_Actinom..>2024-04-28 15:39 1.2K 
[   ]2nt_upstream_Actinom..>2024-04-28 15:40 1.2K 
[   ]2nt_upstream_Actinom..>2024-04-28 15:40 1.1K 
[   ]2nt_upstream_Actinom..>2024-04-28 15:41 1.0K 
[   ]2pept_protein_Actino..>2024-04-28 15:48 1.2K 
[   ]2pept_protein_Actino..>2024-04-28 15:50 1.1K 
[   ]3nt_genomic_Actinoma..>2024-04-28 15:43 2.3K 
[   ]3nt_genomic_Actinoma..>2024-04-28 15:43 1.8K 
[   ]3nt_genomic_Actinoma..>2024-04-28 15:44 1.9K 
[   ]3nt_genomic_Actinoma..>2024-04-28 15:45 1.5K 
[   ]3nt_upstream-noorf_A..>2024-04-28 15:36 2.2K 
[   ]3nt_upstream-noorf_A..>2024-04-28 15:36 1.7K 
[   ]3nt_upstream-noorf_A..>2024-04-28 15:37 1.8K 
[   ]3nt_upstream-noorf_A..>2024-04-28 15:37 1.4K 
[   ]3nt_upstream_Actinom..>2024-04-28 15:39 2.2K 
[   ]3nt_upstream_Actinom..>2024-04-28 15:40 1.7K 
[   ]3nt_upstream_Actinom..>2024-04-28 15:40 1.8K 
[   ]3nt_upstream_Actinom..>2024-04-28 15:41 1.4K 
[   ]3pept_protein_Actino..>2024-04-28 15:49 2.2K 
[   ]3pept_protein_Actino..>2024-04-28 15:50 1.8K 
[   ]4nt_genomic_Actinoma..>2024-04-28 15:43 5.9K 
[   ]4nt_genomic_Actinoma..>2024-04-28 15:43 4.0K 
[   ]4nt_genomic_Actinoma..>2024-04-28 15:44 4.6K 
[   ]4nt_genomic_Actinoma..>2024-04-28 15:45 3.2K 
[   ]4nt_upstream-noorf_A..>2024-04-28 15:36 5.6K 
[   ]4nt_upstream-noorf_A..>2024-04-28 15:36 3.8K 
[   ]4nt_upstream-noorf_A..>2024-04-28 15:37 4.5K 
[   ]4nt_upstream-noorf_A..>2024-04-28 15:37 3.1K 
[   ]4nt_upstream_Actinom..>2024-04-28 15:39 5.7K 
[   ]4nt_upstream_Actinom..>2024-04-28 15:40 3.9K 
[   ]4nt_upstream_Actinom..>2024-04-28 15:40 4.5K 
[   ]4nt_upstream_Actinom..>2024-04-28 15:41 3.1K 
[   ]5nt_genomic_Actinoma..>2024-04-28 15:43 19K 
[   ]5nt_genomic_Actinoma..>2024-04-28 15:44 12K 
[   ]5nt_genomic_Actinoma..>2024-04-28 15:44 15K 
[   ]5nt_genomic_Actinoma..>2024-04-28 15:45 9.2K 
[   ]5nt_upstream-noorf_A..>2024-04-28 15:36 17K 
[   ]5nt_upstream-noorf_A..>2024-04-28 15:36 11K 
[   ]5nt_upstream-noorf_A..>2024-04-28 15:37 14K 
[   ]5nt_upstream-noorf_A..>2024-04-28 15:37 8.9K 
[   ]5nt_upstream_Actinom..>2024-04-28 15:39 18K 
[   ]5nt_upstream_Actinom..>2024-04-28 15:40 11K 
[   ]5nt_upstream_Actinom..>2024-04-28 15:40 15K 
[   ]5nt_upstream_Actinom..>2024-04-28 15:41 9.1K 
[   ]6nt_genomic_Actinoma..>2024-04-28 15:43 61K 
[   ]6nt_genomic_Actinoma..>2024-04-28 15:43 39K 
[   ]6nt_genomic_Actinoma..>2024-04-28 15:44 51K 
[   ]6nt_genomic_Actinoma..>2024-04-28 15:45 32K 
[   ]6nt_upstream-noorf_A..>2024-04-28 15:35 46K 
[   ]6nt_upstream-noorf_A..>2024-04-28 15:36 33K 
[   ]6nt_upstream-noorf_A..>2024-04-28 15:37 40K 
[   ]6nt_upstream-noorf_A..>2024-04-28 15:37 28K 
[   ]6nt_upstream_Actinom..>2024-04-28 15:39 54K 
[   ]6nt_upstream_Actinom..>2024-04-28 15:40 37K 
[   ]6nt_upstream_Actinom..>2024-04-28 15:40 46K 
[   ]6nt_upstream_Actinom..>2024-04-28 15:41 30K 
[   ]7nt_genomic_Actinoma..>2024-04-28 15:43 194K 
[   ]7nt_genomic_Actinoma..>2024-04-28 15:44 129K 
[   ]7nt_genomic_Actinoma..>2024-04-28 15:44 165K 
[   ]7nt_genomic_Actinoma..>2024-04-28 15:45 107K 
[   ]7nt_upstream-noorf_A..>2024-04-28 15:36 133K 
[   ]7nt_upstream-noorf_A..>2024-04-28 15:36 94K 
[   ]7nt_upstream-noorf_A..>2024-04-28 15:37 124K 
[   ]7nt_upstream-noorf_A..>2024-04-28 15:38 84K 
[   ]7nt_upstream_Actinom..>2024-04-28 15:39 164K 
[   ]7nt_upstream_Actinom..>2024-04-28 15:40 114K 
[   ]7nt_upstream_Actinom..>2024-04-28 15:41 145K 
[   ]7nt_upstream_Actinom..>2024-04-28 15:41 97K 
[   ]8nt_genomic_Actinoma..>2024-04-28 15:43 589K 
[   ]8nt_genomic_Actinoma..>2024-04-28 15:44 402K 
[   ]8nt_genomic_Actinoma..>2024-04-28 15:44 530K 
[   ]8nt_genomic_Actinoma..>2024-04-28 15:45 349K 
[   ]8nt_upstream-noorf_A..>2024-04-28 15:36 424K 
[   ]8nt_upstream-noorf_A..>2024-04-28 15:37 277K 
[   ]8nt_upstream-noorf_A..>2024-04-28 15:37 410K 
[   ]8nt_upstream-noorf_A..>2024-04-28 15:38 261K 
[   ]8nt_upstream_Actinom..>2024-04-28 15:39 498K 
[   ]8nt_upstream_Actinom..>2024-04-28 15:40 340K 
[   ]8nt_upstream_Actinom..>2024-04-28 15:41 467K 
[   ]8nt_upstream_Actinom..>2024-04-28 15:41 307K 
[   ]dyads_1nt_sp0-20_gen..>2024-04-28 15:45 1.0K 
[   ]dyads_1nt_sp0-20_gen..>2024-04-28 15:46 1.1K 
[   ]dyads_1nt_sp0-20_gen..>2024-04-28 15:46 1.0K 
[   ]dyads_1nt_sp0-20_gen..>2024-04-28 15:46 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:38 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:38 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:39 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:39 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_1nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_2nt_sp0-20_gen..>2024-04-28 15:45 1.0K 
[   ]dyads_2nt_sp0-20_gen..>2024-04-28 15:46 1.1K 
[   ]dyads_2nt_sp0-20_gen..>2024-04-28 15:46 1.0K 
[   ]dyads_2nt_sp0-20_gen..>2024-04-28 15:46 1.0K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:38 1.0K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:38 1.1K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:38 1.0K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:39 1.0K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:41 1.0K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_2nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_3nt_sp0-20_gen..>2024-04-28 15:45 1.0K 
[   ]dyads_3nt_sp0-20_gen..>2024-04-28 15:46 1.1K 
[   ]dyads_3nt_sp0-20_gen..>2024-04-28 15:46 1.0K 
[   ]dyads_3nt_sp0-20_gen..>2024-04-28 15:46 1.0K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:38 1.0K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:38 1.1K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:38 1.0K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:39 1.0K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:41 1.0K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:42 1.0K 
[   ]dyads_3nt_sp0-20_ups..>2024-04-28 15:42 1.0K